This afternoon on The Daily Dive, Marshall Gunter, CEO of Datametrex AI (TSXV: DM) joins our host Cassandra Leah. Marshall joins us to discuss the COVID-19 pandemic, and how exactly his AI-focused firm became involved with selling COVID-19 test kits within Canada and around the world.
Datametrex AI is a firm primarily focused on technology, via its flagship subsidiary Nexalogy, which is focused on artificial intelligence and machine learning. Recently, the company stepped up to the plate amid the COVID-19 pandemic, distributing its COVID-19 test kits to numerous partners throughout Canada. Clients under its health division include several Canadian mine operators, the film and television production sector in Toronto and Vancouver, and most notably, the firm recently revealed that it is in discussions with Air Canada to potentially provide pre-flight screening to travelers.
Catch the full interview with Marshall below.
FULL DISCLOSURE: DataMetrex AI Limited is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover DataMetrex AI Limited on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.